Hims & Hers Stock Falls After Profit Forecast Cut and Subscriber Warning

Hims & Hers Health (NYSE: HIMS) shares fell about 4% to $22.09 in premarket trading on Tuesday after the telehealth company reported a third-quarter net loss, lowered its full-year profit forecast, and warned that subscriber weakness could continue into the fourth quarter. The company reduced its 2026 adjusted EBITDA guidance to $257 million–$277 million from $275 million–$325 million. It also narrowed its annual revenue forecast to $3.13 billion–$3.15 billion from $3.1 billion–$3.3 billion. The revised revenue midpoint of $3.14 billion is below analysts’ consensus estimate of approximately $3.21 billion. For the fourth quarter, Hims & Hers projected revenue of $875 million–$895 million, below analysts’ consensus estimate of $955.1 million. It also expects adjusted EBITDA of $70 million–$90 million, compared with Wall Street’s estimate of $102.3 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to The Crypto Basic.